The US FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug.

The criteria for consideration of translational and clinical research in Nature Medicine are originality, timeliness and impact on improving human health by addressing unmet clinical needs. Original ...

This scheme has consistently delivered the best returns in its Mid-Cap category across . This scheme has maintained a relatively low level of volatility within its Mid-Cap category over the past 3 ...

This scheme has consistently delivered the best returns in its Small-Cap category across . This scheme has maintained a relatively low level of volatility within its Small-Cap category over the past 3 ...